Ricka, Nicolas
Pellegrin, Gauthier
Fompeyrine, Denis A.
Lahutte, Bertrand
Geoffroy, Pierre A.
Funding for this research was provided by:
Office of Naval Research Global (N62909-20-1-2076)
MyndBlue
Article History
Received: 20 October 2022
Accepted: 12 April 2023
First Online: 25 April 2023
Competing interests
: The clinical study and research presented in this paper were funded by MyndBlue. D.A. Fompeyrine is the CEO and owner of MyndBlue. N. Ricka and G. Pellegrin are employees of MyndBlue. D.A. Fompeyrine did neither contribute to data processing nor algorithms validation. P.A. Geoffroy received fees for consulting from Apneal, Biocodex, Idorsia, Janssen-Cilag, Jazz Pharmaceuticals, Myndblue, Posos, ResilEyes, Withings; and speaker honorarium from: Biocodex, Janssen-Cilag, Jazz Pharmaceuticals, Lundbeck, MySommeil, Withings. B. Lahutte declares no conflicts of interest.